Yasutomi Nishizuka

Total Page:16

File Type:pdf, Size:1020Kb

Yasutomi Nishizuka news and views Obituary hypothesized that it could be linked with PIP2 metabolism. Yasutomi Nishizuka (1932–2004) Nishizuka made another breakthrough in 1982, following an inspiring encounter Ever since the discovery of hormones at with Monique Castagna, who visited the beginning of the last century, the Kobe from Paris. Castagna’s interest was cellular responses to these molecules have the tumour-promoting properties of been high on the research agenda for phorbol esters, and the outcome of her biologists. During the 1970s and 1980s, collaboration with Nishizuka was the answers began to emerge at the molecular finding that these compounds activate level, most notably through the protein kinase C continuously, thus identification of key molecules and events causing uncontrolled cell growth. that follow the binding of a hormone to Born into a medical family, Nishizuka receptors on the cell surface, and transfer had followed the lead of his older brother the hormonal signal to the cell nucleus to Yasuaki, a well-known pathologist, elicit a response. choosing to become a biochemist after So it was that terms and processes that studying medicine. Nishizuka began are now textbook material were unveiled. his scientific career in 1958 as the first The activation of G proteins, which are graduate student of Osamu Hayaishi associated with hormone receptors inside in the Department of Medical Chemistry the cell, leads to the activation of protein at Kyoto University. Hayaishi had just kinase A. Activated G proteins can also returned to Japan from the US National trigger the metabolism of phospholipids Institutes of Health. At the time, Japanese in the cell membrane, particularly cleavage biochemistry was dominated by of phosphatidylinositol-4,5-bisphosphate chemistry-oriented research, mostly aimed (PIP2) into inositol-1,4,5-trisphosphate at identifying new chemical compounds in (IP3) and diacylglycerol, a molecule that metabolites, but Hayaishi introduced the in turn activates protein kinase C. The practice of studying processes and activated protein kinases A and C reactions rather than just end products. phosphorylate other proteins, initiating Consequently, Nishizuka had a thorough a cascade of phosphorylations that hand Discoverer of key grounding in enzymology, and the the activation signal from one protein to protein activation importance of considering the the next until it reaches the nucleus and pathways physiological function of molecules stimulates the correct response. was imprinted on his science. Yasutomi Nishizuka, who died on widely recognized, except for the As a scientist, Nishizuka was very 4 November, was one of the main figures conservation of bioenergy in the high- critical when considering data — I in this biological revolution. In 1989, he energy phosphate discovered by Lipmann, remember him as always being the last was a co-winner of the Lasker award for the and the control of glycolysis by the person to be convinced by new results. But discovery of protein kinase C, along with phosphorylation of key proteins elucidated he was otherwise warm-hearted and gentle, Michael Berridge for the identification by Edmond Fischer and Krebs. So when with a sense of humour. He revered the of IP3 function, Alfred Gilman for the Nishizuka returned to Kyoto University arts, particularly music (he played the discovery of G proteins and their function, in 1965, he started work on an enzyme piano) and painting. His artistic sense was and Edwin Krebs for his pioneering work that phosphorylated other proteins, which evident in his lecture slides — quite an on protein phosphorylation. Gilman and later turned out to be protein kinase A. achievement, because for much of his career Krebs later received the Nobel prize for In January 1969, Nishizuka was each letter had to be stencilled by hand. their contributions. appointed professor of biochemistry at On 17 January 1995, a huge earthquake Nishizuka became interested in protein Kobe University School of Medicine. His struck Kobe, destroying several of the phosphorylation when he visited the new lab had belonged to the Department of university buildings — and damaging Rockefeller University in New York in 1964 Industrial Medicine, and he was surprised Nishizuka’s home. Only two weeks after and 1965 to work with Fritz Lipmann on to find the space occupied by bicycles and this disaster, Nishizuka was named how proteins are synthesized. During his a large bathtub, with no biochemical president of Kobe University, and in the stay, he purified proteins called elongation equipment or lab benches. He wasted ensuing six years of his term of office he factors G and T, which aid the growth of no time in setting up the lab, however, and rebuilt the university and re-established the amino-acid chain, and elucidated the attracted several brilliant medical students it as a competitive academic institution. role of GTP in the process. to join him as postgraduates. The team At the time of his death he was serving Nishizuka’s time with Lipmann and began studying calcium-dependent as president of Hyogo Prefectural his colleagues was comparatively brief, protein phosphorylation. Nishizuka Centre for Adult Disease and on many but it gave him a strong impetus to work originally thought that a calcium- government advisory committees. He will on the biological function of heavily dependent protease triggered the be remembered as a great and charismatic phosphorylated nuclear proteins. kinase activity in brain cell extracts, but scientist. Tasuku Honjo Lipmann had himself studied it soon became clear that the membrane Tasuku Honjo is in the Department of Medical phosphorylated proteins in the 1930s, phospholipid fraction was responsible, Chemistry and Molecular Biology, when he was a visiting scientist at the and the activator turned out to be Kyoto University Faculty of Medicine, Rockefeller. But even in the 1960s, the diacylglycerol. Nishizuka coined the name Kyoto 6068501, Japan. regulatory roles of phosphate were not protein kinase C for this kinase, and he e-mail: [email protected] 966 NATURE | VOL 432 | 23/30 DECEMBER 2004 | www.nature.com/nature © 2004 Nature Publishing Group.
Recommended publications
  • 2004 Albert Lasker Nomination Form
    albert and mary lasker foundation 110 East 42nd Street Suite 1300 New York, ny 10017 November 3, 2003 tel 212 286-0222 fax 212 286-0924 Greetings: www.laskerfoundation.org james w. fordyce On behalf of the Albert and Mary Lasker Foundation, I invite you to submit a nomination Chairman neen hunt, ed.d. for the 2004 Albert Lasker Medical Research Awards. President mrs. anne b. fordyce The Awards will be offered in three categories: Basic Medical Research, Clinical Medical Vice President Research, and Special Achievement in Medical Science. This is the 59th year of these christopher w. brody Treasurer awards. Since the program was first established in 1944, 68 Lasker Laureates have later w. michael brown Secretary won Nobel Prizes. Additional information on previous Lasker Laureates can be found jordan u. gutterman, m.d. online at our web site http://www.laskerfoundation.org. Representative Albert Lasker Medical Research Awards Program Nominations that have been made in previous years may be updated and resubmitted in purnell w. choppin, m.d. accordance with the instructions on page 2 of this nomination booklet. daniel e. koshland, jr., ph.d. mrs. william mccormick blair, jr. the honorable mark o. hatfied Nominations should be received by the Foundation no later than February 2, 2004. Directors Emeritus A distinguished panel of jurors will select the scientists to be honored. The 2004 Albert Lasker Medical Research Awards will be presented at a luncheon ceremony given by the Foundation in New York City on Friday, October 1, 2004. Sincerely, Joseph L. Goldstein, M.D. Chairman, Awards Jury Albert Lasker Medical Research Awards ALBERT LASKER MEDICAL2004 RESEARCH AWARDS PURPOSE AND DESCRIPTION OF THE AWARDS The major purpose of these Awards is to recognize and honor individuals who have made signifi- cant contributions in basic or clinical research in diseases that are the main cause of death and disability.
    [Show full text]
  • 9-Deoxy-A9,A12-13,14
    Proc. Natl. Acad. Sci. USA Vol. 81, pp. 1317-1321, March 1984 Biochemistry 9-Deoxy-A9,A12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma (dehydration product of prostaglandin D2/serum albumin/cell growth inhibition) YOSHIHARU KIKAWA*, SHUH NARUMIYA*, MASANORI FUKUSHIMAt, HIROHISA WAKATSUKAt, AND OSAMU HAYAISHI§ *Department of Medical Chemistry, Kyoto University Faculty of Medicine, Sakyo-ku, Kyoto 606, Japan; tDepartment of Internal Medicine and Laboratory of Chemotherapy, Aichi Cancer Center, Chikusa-ku, Nagoya 464, Japan; tResearch Institute, Ono Pharmaceutical Co., Shimamoto, Mishima, Osaka 618, Japan; and §Osaka Medical College, Daigaku-cho, Takatsuki, Osaka 569, Japan Contributed by Osamu Hayaishi, November 8, 1983 ABSTRACT Incubation of prostaglandin D2 (PGD2) with from Sigma. Dimethylisopropylsilyl (Me2iPrSi) imidazole human plasma yielded a product that has been identified as 9- and methoxyamine hydrochloride were from Tokyo Kasei deoxy-9,10-didehydro-12,13-cdidehydro-13,14-dihydro-PGD2 (Tokyo). Sep-pak silica and Sep-pak C18 cartridges were (9-deoxy-_9,9'2-13,14-dihydro-PGD2). The identification was from Waters Associates. Precoated silica gel plates [G60- based on mass spectrometry, UV spectrometry, mobilities and (F254)] with concentration zones and silica gel 60 for column retention time on TLC and HPLC, and NMR. The conversion chromatography were from Merck. Sephadex LH-20 was a of PGD2 to this product was dependent on the incubation time product of Pharmacia. Solvents used in the extraction of and the amount of plasma added to a reaction mixture and was PGD2 metabolites for identification were distilled before use. abolished by prior boiling.
    [Show full text]
  • Metabolic Tracing of NAD Precursors Using Strategically Labelled Isotopes of NMN
    A thesis submitted in fulfilment of the requirements for the degree of Doctor of Philosophy Metabolic tracing of NAD+ precursors using strategically labelled isotopes of NMN by Lynn-Jee Kim Supervisors Dr. Lindsay E. Wu (Primary) Prof. David A. Sinclair (Joint-Primary) Dr. Lake-Ee Quek (Co-supervisor) School of Medical Sciences Faculty of Medicine Thesis/Dissertation Sheet Surname/Family Name: Kim Given Name/s: Lynn-Jee Abbreviation for degree as give in PhD the University calendar: Faculty: Faculty of Medicine School: School of Medical Sciences + Thesis Title: Metabolic tracing of NAD precursors using strategically labelled isotopes of NMN Abstract 350 words maximum: (PLEASE TYPE) Nicotinamide adenine dinucleotide (NAD+) is an important cofactor and substrate for hundreds of cellular processes involved in redox homeostasis, DNA damage repair and the stress response. NAD+ declines with biological ageing and in age-related diseases such as diabetes and strategies to restore intracellular NAD+ levels are emerging as a promising strategy to protect against metabolic dysfunction, treat age-related conditions and promote healthspan and longevity. One of the most effective ways to increase NAD+ is through pharmacological supplementation with NAD+ precursors such as nicotinamide mononucleotide (NMN) which can be orally delivered. Long term administration of NMN in mice mitigates age-related physiological decline and alleviates the pathophysiologies associated with a high fat diet- and age-induced diabetes. Despite such efforts, there are certain aspects of NMN metabolism that are poorly understood. In this thesis, the mechanisms involved in the utilisation and transport of orally administered NMN were investigated using strategically labelled isotopes of NMN and mass spectrometry.
    [Show full text]
  • Lasker Interactive Research Nom'18.Indd
    THE 2018 LASKER MEDICAL RESEARCH AWARDS Nomination Packet albert and mary lasker foundation November 1, 2017 Greetings: On behalf of the Albert and Mary Lasker Foundation, I invite you to submit a nomination for the 2018 Lasker Medical Research Awards. Since 1945, the Lasker Awards have recognized the contributions of scientists, physicians, and public citizens who have made major advances in the understanding, diagnosis, treatment, cure, and prevention of disease. The Medical Research Awards will be offered in three categories in 2018: Basic Research, Clinical Research, and Special Achievement. The Lasker Foundation seeks nominations of outstanding scientists; nominations of women and minorities are encouraged. Nominations that have been made in previous years are not automatically reconsidered. Please see the Nomination Requirements section of this booklet for instructions on updating and resubmitting a nomination. The Foundation accepts electronic submissions. For information on submitting an electronic nomination, please visit www.laskerfoundation.org. Lasker Awards often presage future recognition of the Nobel committee, and they have become known popularly as “America’s Nobels.” Eighty-seven Lasker laureates have received the Nobel Prize, including 40 in the last three decades. Additional information on the Awards Program and on Lasker laureates can be found on our website, www.laskerfoundation.org. A distinguished panel of jurors will select the scientists to be honored with Lasker Medical Research Awards. The 2018 Awards will
    [Show full text]
  • Suppression of Poly(ADP-Ribose)
    Proc. Nati. Acad. Sci. USA Vol. 81, pp. 7132-7136, November 1984 Cell Biology Induction of murine teratocarcinoma cell differentiation by suppression of poly(ADP-ribose) synthesis (NADW/retinoic acid/3-aminobenzamide/immunofluorescence) YASUHIRO OHASHI*t, KUNIHIRO UEDA*t, OSAMU HAYAISHI*§, KouICHI IKAI¶, AND OTSURA NIWAII Departments of *Medical Chemistry, ¶Dermatology, and "Experimental Radiology, Kyoto University Faculty of Medicine, Yoshida, Sakyo-ku, Kyoto 606, Japan Contributed by Osamu Hayaishi, July 27, 1984 ABSTRACT Poly(ADP-ribose) synthesizing activity in present study, we report a marked decrease in nuclear po- mouse teratocarcinoma EC-Al cells decreased markedly dur- ly(ADP-ribose) synthesizing activity at a very early stage of ing differentiation induced by retinoic acid; the activities as- differentiation of teratocarcinoma cells induced by retinoic sayed in permeabilized cells decreased to 25% and 10% of the acid. Furthermore, we present evidence suggesting that ex- activity of control (uninduced cells) 2 and 3 days, respectively, ogenously added inhibitors of poly(ADP-ribose) synthetase after the addition of 0.1 ,uM retinoic acid to the culture medi- can induce the differentiation of these cells. um. This change preceded changes in morphology and DNA synthesis, which became prominent after 4 days. The decrease MATERIALS AND METHODS in poly(ADP-ribose) synthesizing activity appeared to be caused by a diminution of the synthetase protein and not by a Chemicals. [adenine-U-14C]NAD+ (266 Ci/mol; 1 Ci = 37 decrease in its catalytic activity, because the full activity dis- GBq) and [methyl-3H]dTTP (30 Ci/mmol) were purchased closed by DNase I treatment decreased in parallel, albeit at from Amersham.
    [Show full text]
  • Effects of 5-Hydroxykynurenamine, a New Serotonin Metabolite
    Proc. Nat. Acad. Sci. USA Vol. 71, No. 1, pp. 122-124, January 1974 Effects of 5-Hydroxykynurenamine, a New Serotonin Metabolite, on Isolated Dog Basilar Arteries (serotonin/amine/antagonist/artery) NOBORU TODA*, TAKASHI TOKUYAMAt, SIRO SENOHt, FUSAO HIRATA§, AND OSAMU HAYAISHI§ * Department of Pharmacology, and § Department of Medical Chemistry, Kyoto University Faculty of Medicine, Kyoto; t Department of Chemistry, Osaka City University Faculty of Science, Osaka; and $ Central Research Institute, Suntory Ltd., Osaka, Japan Contributed by Osamu Hayaishi, September 10, 1973 ABSTRACT Serotonin and 5-hydroxykynurenamine HK and serotonin were added directly to the bathing me- caused dose-related contractions in the spiral strips of dium in cumulative concentrations at the time when the dose- dog basilar arteries. The potency of 5-hydroxykynuren- amine was approximately 1/100 that of serotonin, the response curve was obtained. former frequently causing a transient relaxation preceding the contraction. The contractile responses to 5-hydroxy- RESULTS kynurenamine and serotonin were attenuated by methy- Serotonin in concentrations ranging from 10-9 to 10-5 M sergi(le. Treatment with 5-hydroxykynurenamine inhib- caused a dose-related increase in the tension of basilar arterial ited the response to serotonin, and this inhibitory effect was not completely reversed by removal of 5-hydroxy- strips (Fig. 1A). Contractile responses to serotonin were kvnurenamine from the bathing medium. The contractile reproducible five times when preparations were repeatedly response to K+ was only slightly attenuated by high con- washed and equilibrated in normal solutions for 40-60 min. centrations of 5-hydroxykynurenamine. It appears that 5-HEK (5 X 10-' to 5 X 10-5 M) caused slowly developing 5-hydroxykynurenamine and serotonin share receptors in contractions in a dose-dependent manner (Fig.
    [Show full text]
  • IUBMB Newsletter Issue 2.Pdf
    IUBMB NEWS Issue 2 October 2016 President’s Message IUBMB aims to promote research and education in In This Issue Biochemistry and Molecular Biology. In this regard, over the President’s Message years we have channelled great efforts into the research aspects of our science. We now consider it timely to turn our Report on the 16th IUBMB attention to educational initiatives. Conference / Young To address this aim and in collaboration with FEBS, we are organising a conference on Education in Biochemistry and Molecular Biology, to be held in Scientists’ Program Rehovot (Israel) in September 2017. The conference seeks to provide a think-tank Tang Prize Foundation setting in which to draw up ideas to improve the current approach to teaching these subjects, and to generate a series of recommendations to be shared with Awardees / IUBMB Travel the educational community. In this regard, this conference will serve to propel the Fellowships changes that are required to bring education in biochemistry and molecular biology st at all levels into the 21 century. Another Way to Think About Another important aspect of education is to provide young scientists from Disease by Gregory Petsko developing countries the opportunity to attend international congresses and meetings. IUBMB is firmly committed to this endeavour and devotes significant Retrospective — financial resources to this end. Given that the number of applications from African countries is very low, I wish to encourage our young African colleagues to apply Osamu Hayaishi and benefit from IUBMB travel awards and Wood-Whelan fellowships. An Appreciation — IUBMB is also launching a new activity, namely Focused Meetings.
    [Show full text]
  • From a Pseudomonad, Catalyzes the Oxygenation of L-Lysi an A,E
    Proc. Nat. Acad. Sci. USA Vol. 69, No. 12, pp. 3723-3726, December 1972 Alkylamine-Dependent Amino-Acid Oxidation by Lysine Monooxygenase- Fragmented Substrate of Oxygenase (Pseudomonas/enzyme/aminefamide/flavoprotein) SHOZO YAMAMOTO, TAKASHI YAMAUCHI, AND OSAMU HAYAISHI Department of Medical Chemistry, Kyoto University Faculty of Medicine, Kyoto, Japan Contributed by Osamu Hayaishi, October 10, 1972d ABSTRACT Lysine monooxygenase catalyzes the cIxy- a significant role in the catalysis of the enzyme. It would be of a rre- genative decarboxylation of L-lysine and produces coi heefoeto investigate the reaction of the enzyme sponding acid amide. L-Alanine was inactive as substriate. However, when propylamine was present, oxidation,Ibut in the presence of both a-monoamino acids and alkylamines- not oxygenation, of alanine was demonstrated with the of various carbon chain lengths-the two fragments of the oxygenase. Alanine was converted to pyruvate, with the normal substrate. liberation of ammonia and hydrogen peroxide, but proyI~yl- amine remained unchanged. Other a-monoamino accids MATERIALS AND METHODS were also oxidized in the presence of alkylamines wi various carbon chain lengths. The highest oxidase actiiV~it Lysine monooxygenase was purified and assayed as described was observed when the total chain length of both anm Lio (1). Pyruvate was determined with the aid of rabbit-muscle acid and amine was nearly identical with that of lysiine, lactate dehydrogenase Type II (Sigma) (4) or as its hydrazone Available evidence indicates that the amine-depend,lent (5). Oxygen consumption was followed by an oxygen electrode 5ine amino-acid oxidase activity is associated with the lys (1). As the solubility of oxygen in water decreases when the oxygenase activity.
    [Show full text]
  • Prof. Dr. Yasutomi Nishizuka Prof. Dr. Yasutomi Nishizuka
    21.11.2017 Prof. Dr. Yasutomi Nishizuka | Schering Stiftung Prof. Dr. Yasutomi Nishizuka | Print | Award Person Prof. Dr. Yasutomi Nishizuka Name: Yasutomi Nishizuka Date of Birth: July 12, 1932 Place of Birth: Japan Address: President, Kobe University School of Medicine, Department of Biochemistry, Kobe 657-8501, Japan Education 1952-1957 M.D., Kyoto University Faculty of Medicine 1958-1962 Ph.D., Kyoto University Graduate School Experience 1962-1964 Research Associate (Prof. Osamu Hayaishi's Laboratory), Department of Medical Chemistry, Kyoto University, Faculty of Medicine, Kyoto, Japan 1964-1968 Associate Professor, Department of Medical Chemistry, Kyoto University, Faculty of Medicine, Kyoto, Japan 1964-1965 Guest Investigator as NIH International Postdoctoral Research Fellow (Prof. Fritz Lipmann's Laboratory), Rockefeller University, New York, NY, USA 1969-1995 Professor and Chairman, Department of Biochemistry, Kobe University School of Medicine, Kobe, Japan 1980-1985 Professor (joint appointment), Department of Cell Biology, National Institute for Basic Biology, Okazaki, Japan 1984 Visiting Professor (one month), Harvard Medical School, Boston, MA, USA 1989-1992 Professor (joint appointment), Department of Biology, Kobe University School of Science, Kobe, Japan 1992-1995 Director (joint appointment), Biosignal Research Center, Kobe University, Kobe, Japan since 1995 President, Kobe University, Kobe, Japan Awards and Grants 1986 Award of the Japan Academy 1987 Cultural Merit Prize, Japanese Government 1988 Alfred P. Sloan Jr. Prize,
    [Show full text]
  • Communicating Biochemistry: Meetings and Events
    © The Authors. Volume compilation © 2011 Portland Press Limited Chapter 3 Communicating Biochemistry: Meetings and Events Ian Dransfield and Brian Beechey Scientific conferences organized by the Biochemical Society represent a key facet of activity throughout the Society’s history and remain central to the present mission of promoting the advancement of molecular biosciences. Importantly, scientific conferences are an important means of communicating research findings, establishing collaborations and, critically, a means of cementing the community of biochemical scientists together. However, in the past 25 years, we have seen major changes to the way in which science is communicated and also in the way that scientists interact and establish collabo- rations. For example, the ability to show videos, “fly through” molecular structures or show time-lapse or real-time movies of molecular events within cells has had a very positive impact on conveying difficult concepts in presentations. However, increased pressures on researchers to obtain/maintain funding can mean that there is a general reluctance to present novel, unpublished data. In addition, the development of email and electronic access to scientific journals has dramatically altered the potential for communi- cation and accessibility of information, perhaps reducing the necessity of attending meetings to make new contacts and to hear exciting new science. The Biochemical Society has responded to these challenges by progressive development of the meetings format to better match the
    [Show full text]
  • Happy Holidays ASBMB Membersbayside Biomolecules
    SUBMIT YOUR LATE BREAKING MEETING ABSTRACTS BY FEB 25 January 2009 Happy Holidays ASBMB MembersBayside Biomolecules American Society for Biochemistry and Molecular Biology Edited by Ajit Varki, University of California, San Diego, Richard D. Cummings, Emory University School of Medicine, Atlanta, Jeffrey D. Esko, University of California, San Diego, Hudson H. Freeze, Burnham Institute for Medical Research, La Jolla, Pamela Stanley, Albert Einstein College of Medicine of Yeshiva University, New York, Carolyn R. Bertozzi, University of California, Berkeley, Gerald W. Hart, Johns Hopkins University of School of Medicine, Baltimore, and Marilynn E. Etzler, University of California, Davis he sugar chains of cells—known collectively as glycans—play a variety of impressive, critical, and often Tsurprising roles in biological systems. Glycobiology is the study of the roles of glycans in the growth and development, function, and survival of an organism. Glyco-related processes, described in vivid detail in the text, have become increasingly significant in many areas of basic research as well as biomedicine and biotechnology. This new edition of Essentials of Glycobiology covers the general principles and describes the structure and biosynthesis, diversity, and function of glycans and their relevance to both normal physiologic processes and human disease. Several new chapters present significant advances that have occurred since the publication of the first edition. Three sections of note describe organismal diversity, advances in our understanding of disease states and related therapeutic applications, and the genomic view of glycobiology. “Glycomics,” analogous to genomics and proteomics, is the systematic study of all glycan structures of a given cell type or organism and paves the way for a more thorough understanding of the functions of these ubiquitous molecules.
    [Show full text]
  • EURAXESS Links Japan Newsletter
    2014 September EURAXESS LINKS Issue 67 JAPAN Dear Colleagues, Welcome to the September edition of the EURAXESS Links Japan Newsletter. This newsletter looks at the latest developments and funding opportunities in and between Europe and Japan. This month features some comprehensive information about the EURAXESS Science Slam Japan 2014, which now on rails with open submissions for contestants and attendees, a tentative schedule, VIP visits, a selected jury and with a new, fresh website: scienceslamjapan2014.splashthat.com (share it, This Newsletter is also it’s free!). Find also an exclusive interview with Mugiko KOMATSUDA, last intended as a year’s winner, who gives us her insights on the role of communication for communication tool with scientists in our times. If you are not one of the brave who’ll present in front of a you all, so please do not hesitate to contact us full room, you are still warmly welcome to attend the event on 10 November at at [email protected] for Tokyo Tech. Mark your calendars for what promises to be a nice, relaxed comments, corrections or if networking and fun science moment with food and drinks! you want to advertise for a particular funding scheme or In this issue we go through some of the numerous news and developments in event. recent policy for research; with a particularly dense section on Japan in coherence with the important announcements made by the government and MEXT in late August and early September. Following the news section, you will find, as usual a wealth of Grants and Fellowships, with many JSPS deadlines coming soon; job offers; and events of interest both in Europe and Japan.
    [Show full text]